216 related articles for article (PubMed ID: 26265409)
21. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A
J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
Cossu M; Andracco R; Santaniello A; Marchini M; Severino A; Caronni M; Radstake T; Beretta L
Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111
[TBL] [Abstract][Full Text] [Related]
23. Microparticles: potential new contributors to the pathogenesis of systemic sclerosis?
de Oliveira SM; de Azevedo Teixeira IL; França CN; de Oliveira Izar MC; Kayser C
Adv Rheumatol; 2023 Apr; 63(1):19. PubMed ID: 37098600
[TBL] [Abstract][Full Text] [Related]
24. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.
Weigold F; Günther J; Pfeiffenberger M; Cabral-Marques O; Siegert E; Dragun D; Philippe A; Regensburger AK; Recke A; Yu X; Petersen F; Catar R; Biesen R; Hiepe F; Burmester GR; Heidecke H; Riemekasten G
Arthritis Res Ther; 2018 Mar; 20(1):52. PubMed ID: 29566745
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
26. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
27. Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis.
Leleu D; Levionnois E; Laurent P; Lazaro E; Richez C; Duffau P; Blanco P; Sisirak V; Contin-Bordes C; Truchetet ME
Front Immunol; 2020; 11():532177. PubMed ID: 33193304
[TBL] [Abstract][Full Text] [Related]
28. Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis.
Butt S; Jeppesen JL; Iversen LV; Fenger M; Eugen-Olsen J; Andersson C; Jacobsen S
PLoS One; 2021; 16(2):e0247256. PubMed ID: 33617568
[TBL] [Abstract][Full Text] [Related]
29. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease.
Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Shimizu K; Sato S
Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266
[TBL] [Abstract][Full Text] [Related]
30. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.
Giannella A; Radu CM; Franco L; Campello E; Simioni P; Avogaro A; de Kreutzenberg SV; Ceolotto G
Cardiovasc Diabetol; 2017 Sep; 16(1):118. PubMed ID: 28927403
[TBL] [Abstract][Full Text] [Related]
31. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.
Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; He M; Yamada M; Suzuki S; Yanai M; Kurosawa S; Yamaya M; Kubo H
Thorax; 2012 Dec; 67(12):1067-74. PubMed ID: 22843558
[TBL] [Abstract][Full Text] [Related]
32. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
[TBL] [Abstract][Full Text] [Related]
33. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
34. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
[TBL] [Abstract][Full Text] [Related]
35. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1.
Andersen GN; Caidahl K; Kazzam E; Petersson AS; Waldenström A; Mincheva-Nilsson L; Rantapää-Dahlqvist S
Arthritis Rheum; 2000 May; 43(5):1085-93. PubMed ID: 10817563
[TBL] [Abstract][Full Text] [Related]
36. The association between endothelial microparticles and inflammation in patients with systemic sclerosis and Raynaud's phenomenon as detected by functional imaging.
Jung C; Drummer K; Oelzner P; Figulla HR; Boettcher J; Franz M; Betge S; Foerster M; Wolf G; Pfeil A
Clin Hemorheol Microcirc; 2015; 61(3):549-57. PubMed ID: 26410864
[TBL] [Abstract][Full Text] [Related]
37. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.
De Luca G; Bosello SL; Berardi G; Rucco M; Canestrari G; Correra M; Mirone L; Forni F; Di Mario C; Danza FM; Pirronti T; Ferraccioli G
Rheumatology (Oxford); 2015 Nov; 54(11):1991-9. PubMed ID: 26106211
[TBL] [Abstract][Full Text] [Related]
38. Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.
Hosseinzadeh S; Noroozian M; Mortaz E; Mousavizadeh K
Metab Brain Dis; 2018 Feb; 33(1):293-299. PubMed ID: 29209923
[TBL] [Abstract][Full Text] [Related]
39. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
40. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head.
Kang P; Shen B; Yang J; Pei F
Thromb Res; 2008; 123(2):367-73. PubMed ID: 18495220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
